These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19706638)

  • 1. Empty handed: a call for an international registry of risk stratification to reduce the 'sudden-ness' of death in patients with non-compaction cardiomyopathy.
    Caliskan K; Kardos A; Szili-Torok T
    Europace; 2009 Sep; 11(9):1138-9. PubMed ID: 19706638
    [No Abstract]   [Full Text] [Related]  

  • 2. Preventing sudden death in patients with cardiomyopathies.
    Li A; Zaidi A; Camm AJ
    Practitioner; 2007 Jun; 251(1695):44, 49-51, 53-4 passim. PubMed ID: 17654875
    [No Abstract]   [Full Text] [Related]  

  • 3. Implantable cardioverter defibrillator therapy for non-ischaemic cardiomyopathy. What is the role of programmed electrical stimulation?
    Plummer C
    Europace; 2009 Mar; 11(3):273-5. PubMed ID: 19164361
    [No Abstract]   [Full Text] [Related]  

  • 4. Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy.
    Maron BJ
    Circulation; 2010 Jan; 121(3):445-56. PubMed ID: 20100987
    [No Abstract]   [Full Text] [Related]  

  • 5. [Risk stratification for sudden cardiac death: should we juist consider ejection fraction?].
    Paolucci M; Cattafi G; Magenta G; Vecchi MR; Schirru M; Lunati M
    G Ital Cardiol (Rome); 2008 Oct; 9(10 Suppl 1):27S-32S. PubMed ID: 19195303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk assessment in hypertrophic cardiomyopathy.
    Ward D
    Heart; 2009 Mar; 95(5):421; author reply 421. PubMed ID: 19218266
    [No Abstract]   [Full Text] [Related]  

  • 7. Sudden death risk in older athletes: increasing the denominator.
    Tunstall Pedoe DS
    Br J Sports Med; 2004 Dec; 38(6):671-2. PubMed ID: 15562156
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiomyopathy.
    Cruickshank S
    Nurs Stand; 2004 Feb 18-24; 18(23):46-52; quiz 54-6. PubMed ID: 15017816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardiovascular sudden death].
    Loire R
    Ann Pathol; 1999 Jun; 19(3):203-11. PubMed ID: 10456194
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk stratification for sudden cardiac death.
    Sabir IN; Usher-Smith JA; Huang CL; Grace AA
    Prog Biophys Mol Biol; 2008; 98(2-3):340-6. PubMed ID: 19351522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of hypertrophic cardiomyopathy-related deaths: theory and practice.
    Elliott P; Spirito P
    Heart; 2008 Oct; 94(10):1269-75. PubMed ID: 18653582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk assessment in hypertrophic cardiomyopathy.
    Saumarez RC
    Heart; 2009 Mar; 95(5):421; author reply 421. PubMed ID: 19218265
    [No Abstract]   [Full Text] [Related]  

  • 13. Risk stratification using T-wave alternans: more questions waiting to be answered.
    Hohnloser SH
    J Cardiovasc Electrophysiol; 2008 Oct; 19(10):1043-4. PubMed ID: 18479332
    [No Abstract]   [Full Text] [Related]  

  • 14. [Epidemiology of sudden cardiac death].
    Andresen D
    Herzschrittmacherther Elektrophysiol; 2005 Jun; 16(2):73-7. PubMed ID: 15997353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator.
    Roes SD; Borleffs CJ; van der Geest RJ; Westenberg JJ; Marsan NA; Kaandorp TA; Reiber JH; Zeppenfeld K; Lamb HJ; de Roos A; Schalij MJ; Bax JJ
    Circ Cardiovasc Imaging; 2009 May; 2(3):183-90. PubMed ID: 19808591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatal left-dominant arrhythmogenic cardiomyopathy involving a 25-year old professional football player: could it have been prevented?
    Busardò FP; Cappato R; D'Ovidio C; Frati P; Riezzo I; Fineschi V
    Int J Cardiol; 2014 Jun; 174(2):423-5. PubMed ID: 24768383
    [No Abstract]   [Full Text] [Related]  

  • 17. Extensive myocardial fibrosis in a patient with hypertrophic cardiomyopathy and ventricular tachycardia without traditional high-risk features.
    Bongioanni S; Spirito P; Masi AS; Chiribiri A; Bonamini R; Conte MR
    Circ Cardiovasc Imaging; 2009 Jul; 2(4):349-50. PubMed ID: 19808616
    [No Abstract]   [Full Text] [Related]  

  • 18. Primary prevention of sudden cardiac death.
    Kirchhof P; Breithardt G; Eckardt L
    Heart; 2006 Dec; 92(12):1873-8. PubMed ID: 17105896
    [No Abstract]   [Full Text] [Related]  

  • 19. Programmed ventricular stimulation for risk stratification in patients with tetralogy of Fallot: a Bayesian perspective.
    Khairy P
    Nat Clin Pract Cardiovasc Med; 2007 Jun; 4(6):292-3. PubMed ID: 17522719
    [No Abstract]   [Full Text] [Related]  

  • 20. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death.
    Corrado D; Basso C; Schiavon M; Pelliccia A; Thiene G
    J Am Coll Cardiol; 2008 Dec; 52(24):1981-9. PubMed ID: 19055989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.